Suppr超能文献

内分泌学中的机制:垂体炎:诊断与治疗。

MECHANISMS IN ENDOCRINOLOGY: Hypophysitis: diagnosis and treatment.

机构信息

Department of Endocrinology, Guy's & St. Thomas' NHS Foundation Trust, London, UK.

Department of Endocrinology, Kings College Hospital NHS Foundation Trust, London, UK.

出版信息

Eur J Endocrinol. 2018 Sep;179(3):R151-R163. doi: 10.1530/EJE-17-0009. Epub 2018 Jun 7.

Abstract

Hypophysitis is a rare condition characterised by inflammation of the pituitary gland, usually resulting in hypopituitarism and pituitary enlargement. Pituitary inflammation can occur as a primary hypophysitis (most commonly lymphocytic, granulomatous or xanthomatous disease) or as secondary hypophysitis (as a result of systemic diseases, immunotherapy or alternative sella-based pathologies). Hypophysitis can be classified using anatomical, histopathological and aetiological criteria. Non-invasive diagnosis of hypophysitis remains elusive, and the use of currently available serum anti-pituitary antibodies are limited by low sensitivity and specificity. Newer serum markers such as anti-rabphilin 3A are yet to show consistent diagnostic value and are not yet commercially available. Traditionally considered a very rare condition, the recent recognition of IgG4-related disease and hypophysitis as a consequence of use of immune modulatory therapy has resulted in increased understanding of the pathophysiology of hypophysitis. Modern imaging techniques, histological classification and immune profiling are improving the accuracy of the diagnosis of the patient with hypophysitis. The objective of this review is to bring readers up-to-date with current understanding of conditions presenting as hypophysitis, focussing on recent advances and areas for future development. We describe the presenting features, investigation and diagnostic approach of the patient with likely hypophysitis, including existing conventional techniques and those in the research/development arena. Hypophysitis usually results in acute and persistent pituitary hormone deficiency requiring long-term replacement. Management of hypophysitis includes control of the inflammatory pituitary mass using a variety of treatment strategies including surgery and medical therapy. Glucocorticoids remain the mainstay of medical treatment but other immunosuppressive agents (e.g. azathioprine, rituximab) show benefit in some cases, but there is a need for controlled studies to inform practice.

摘要

垂体炎是一种罕见的疾病,其特征为垂体炎症,通常导致垂体功能减退和垂体增大。垂体炎可分为原发性(最常见的淋巴细胞性、肉芽肿性或黄色瘤性疾病)或继发性(由于全身疾病、免疫治疗或其他鞍区病变)。垂体炎可根据解剖学、组织病理学和病因学标准进行分类。目前,非侵入性诊断垂体炎仍然难以实现,并且目前可用的血清抗垂体抗体的使用受到低敏感性和特异性的限制。更新的血清标志物,如抗 rabphilin 3A,尚未显示出一致的诊断价值,并且尚未商业化。传统上被认为是一种非常罕见的疾病,最近认识到 IgG4 相关疾病和免疫调节治疗引起的垂体炎导致对垂体炎病理生理学的理解增加。现代成像技术、组织学分类和免疫分析正在提高垂体炎患者诊断的准确性。本文的目的是使读者了解当前对表现为垂体炎的疾病的认识,重点介绍最新进展和未来发展领域。我们描述了可能患有垂体炎的患者的临床表现、检查和诊断方法,包括现有的常规技术和研究/开发领域的技术。垂体炎通常导致急性和持续性垂体激素缺乏,需要长期替代治疗。垂体炎的治疗包括使用各种治疗策略控制炎症性垂体肿块,包括手术和药物治疗。糖皮质激素仍然是主要的药物治疗方法,但其他免疫抑制剂(如硫唑嘌呤、利妥昔单抗)在某些情况下显示出益处,但需要进行对照研究以指导实践。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验